1Brambilla E,Travis WD,Colby TV,et al.The New World Health Or-ganization classification of lung tumours[Z].2001.
2Weinstein HJ,Hudson MM,Lymphomas LP.Library of congress[M].Berlin:Springer Press,2007.
3Tubergen DG,Krailo MD,Meadows AT,et al.Comparison of treatmentregimens for pediatric lymphoblastic non-Hodgkin's lymphoma:A Chil-drens Cancer Group study[J].J Clin Oncol,1995,13(6):1368-1376.
4Amylon MD,Shuster J,Pullen J,et al.Intensive high-dose asparagi-nase consolidation improves survival for pediatric patients with T cell a-cute lymphoblastic leukemia and advanced stage lymphoblastic lympho-ma:A Pediatric Oncology Group study[J].Leukemia,1999,13(3):335-342.
5Reiter A,Schrappe M,Ludwig WD,et al.Intensive ALL-type therapywithout local radiotherapy provides a 90%event-free survival for chil-dren with T-cell lymphoblastic lymphoma:A BFM group report[J].Blood,2000,95(2):416-421.
6Burkhardt B,Woessmann W,Zimmermann M,et al.Impact of cranialradiotherapy on central nervous system prophylaxis in children and ado-lescents with central nervous system-negative stageⅢorⅣlympho-blastic lymphoma[J].J Clin Oncol,2006,24(3):491-499.
7Cairo MS,Gerrard M,Sposto R,et al.Results of a randomized interna-tional study of high-risk central nervous system B non-Hodgkin lym-phoma and B acute lymphoblastic leukemia in children and adolescents[J].Blood,2007,109(7):2736-2743.
8Gerrard M,Cairo MS,Weston C,et al.Results of the FAB LMB 96 in-ternational study in children and adolescents(C+A)with localised,re-sected B cell lymphoma[large cell(LCL),Burkitt's(BL)and Burkitt-like(BLL)] [J].J Clin Oncol,2003,22:795.
9Patte C,Auperin A,Gerrard M,et al.Results of the randomized inter-national FAB/LMB96 trial for intermediate risk B-cell non-Hodgkinlymphoma in children and adolescents:It is possible to reduce treatmentfor the early responding patients[J].Blood,2007,109(7):2773-2780.
10Reiter A,Schrappe M,Tiemann M,et al.Improved treatment resultsin childhood B-cell neoplasms with tailored intensification of therapy:A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM90[J].Blood,1999,94(10):3294-3306.
5Percy CL,Smith MA,Tong T,et al.Lymphomas and reticuloendothelial neoplasms.Cancer incidence and survival among children and adolescent.United States SEER program 1975-1995.NIH,1999,99-4649:35-49.
6Takeuchi M,Sato Y,Yoshino T.The frequency of malignant lymphoma subtypes based on World Health Organization(WHO)classification Nihon Rinsho,2014,72:436-440.
7Tamaru J.Pathological diagnosis of Hodgkin lymphoma.Nihon Rinsho,2014,72:450-455.
8Brusamolino E,Bacigalupo A,Barosi G,et al.Classical Hodgkin's lymphoma in adults:guidelines of the Italian Society of Hematology,the Italian Society of Experimental Hematology,and the Italian Group for Bone Marrow Transplantation on initial work-up,management,and follow-up.Haematologica,2009,94:550-565.
9Magrath IT,Adde M,Shad A,et al.Adults and children with small lion-cleaved cell lymphoma have a similar ext-client outcome when treated with the Salne chemotherapy regimen.J Clin Oncol,1996,14:925-934.
10Reiter A,Schrappe M,Ludwing WD,et al.Intensive ALL-type therapy without local radiotherapy provides a 90%event-free survival for children with T-cell lymphohlastic lymphoma:a BFM group report.Blood,2000,95:416-421.
